tiprankstipranks
Steris backs FY23 adjusted EPS view $8.40-$8.60, consensus $8.49
The Fly

Steris backs FY23 adjusted EPS view $8.40-$8.60, consensus $8.49

Based on foreign currency forward rates through March 31, 2023, STERIS now anticipates additional currency headwinds. The total revenue impact is now expected to be approximately $150 million, an increase from prior expectations of $100 million. As a result, as reported revenue is now anticipated to grow 8% compared with prior expectations of 9% growth. Constant currency organic revenue expectations are unchanged at 10% growth. The impact from foreign currency rate changes is now expected to impact adjusted earning per diluted share by approximately $0.15 for fiscal 2023, compared with prior expectations of approximately $0.10. The adjusted earnings per diluted share range of $8.40 to $8.60 remains unchanged, although the Company believes the high-end of the range is less likely due to the additional currency headwind.

Published first on TheFly

See today’s best-performing stocks on TipRanks >>

Read More on STE:

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100
Bitcoin

Popular Articles